A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

Trial Profile

A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Autologous-non-bulbar-dermal-sheath-fibroblast-therapy-RepliCel-Life-Sciences (Primary)
  • Indications Tendon injuries
  • Focus Adverse reactions
  • Acronyms ReaCT-X
  • Sponsors RepliCel Life Sciences
  • Most Recent Events

    • 06 Apr 2016 Status changed from not yet recruiting to withdrawn prior to enrolmentas the study conduct does not meet corporate objectives of sponsor, according to ClinicalTrials.gov record.
    • 28 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top